Clinical Research Directory

Inclusion Criteria: * Diagnosis of infrarenal abdominal aortic aneurysm * Plan to treat with Minos Abdominal Aortic Stent-Graft and Delivery System * Voluntary participation and completion of Informed Consent Form, with willingness to participate in follow-up to 5 years post-procedure Exclusion Criteria: * Subjects in whom use of the Minos™ Abdominal Aortic Stent-Graft and Delivery System is contraindicated, as follows: * Severe stenosis or calcification near the aneurysm, leading to difficulty in achieving apposition of vessel wall and stent graft. * Difficult access due to severe stenosis or tortuosity in the iliac artery or femoral artery. * Subjects with ruptured aneurysm or acute aneurysm. * Subjects with an infectious aneurysm. * Those who are allergic to contrast agents or unable to tolerate contrast agents due to renal insufficiency. * Patients with severe coagulation disorder and/or high risk of postoperative hemorrhage. * Aneurysmal neck angulation greater than 60°. * Patients with blood supply to vital organs originating from the aneurysmal sac. * Patients with other comorbidities and whose life expectancy does not exceed one year. * Subjects with connective tissue diseases, such as Marfan syndrome. * Minors and pregnant women. * Subjects who are allergic to nitinol. * Subjects who are considered not suitable for treatment with stent graft.